Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
Abstract
No abstract availableKeywords
Funding Information
- Aase and Ejnar Danielsens Foundation
- The Danish Cancer Society
- The Lundbeck Foundation
- The Danish Council for Independent Research, Technology and Production Sciences (09-070021)
This publication has 41 references indexed in Scilit:
- Leukotriene C4 induces migration of human monocyte–derived dendritic cells without loss of immunostimulatory functionBlood, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- TLR4 Engagement during TLR3-Induced Proinflammatory Signaling in Dendritic Cells Promotes IL-10–Mediated Suppression of Antitumor ImmunityCancer Research, 2011
- Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-AnalysisPLOS ONE, 2011
- Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell CarcinomaClinical Cancer Research, 2011
- Induction of CD8+T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant GliomaJournal of Clinical Oncology, 2011
- PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsBlood, 2010
- Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 byIL-12p70mRNA–Transfected Dendritic CellsCancer Research, 2008
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during MaturationCancer Research, 2008
- DC-based cancer vaccinesJournal of Clinical Investigation, 2007